Music |
Video |
Movies |
Chart |
Show |
FDA Approval of Atezolizumab for Advanced Bladder Cancer (OncLive) View |
The FDA Approval of Atezolizumab in Bladder Cancer (OncLive) View |
New Immunotherapy Approved for Metastatic Bladder Cancer (Mayo Clinic) View |
Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, and More (OncLive) View |
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma (ecancer) View |
FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and a Breakthrough Designation in NSCLC (OncLive) View |
Novel Agents in NHL, FDA Approval in Myeloma, Combination Trials With Atezolizumab, and More (OncLive) View |
FDA approves Atezolizumab as Adjuvant Treatment for Non-small Cell Lung Cancer (MedSynapse) View |
FDA approves combo immunotherapy for mesothelioma, atezolizumab strikes out in ovarian cancer,... (MDedge: news and insights for busy physicians) View |
FIRST TREATMENT FOR SPECIFIC BLADCER CANCER IN THAN 30 YEARS (Author Deb Nicholson) View |